Table 1.
Demographics and clinical characteristics of the study subjects*
| Parameters | Control (N = 236) | CAD N = (115) | P |
|---|---|---|---|
| Age (years) | 51.7 ± 12.2 | 51.5 ± 14.3 | 0.854 |
| Gender (M/F) | 180/107 | 82/31 | 0.079 |
| Body mass index (Kg/m2) | 22.7 ± 4.2 | 22.7 ± 3.9 | 0.886 |
| Systolic blood pressure (mm/Hg) | 123.0 ± 21.2 | 124.9 ± 23.0 | 0.931 |
| Diastolic blood pressure (mm/Hg) | 76.4 ± 11.3 | 76.4 ± 10.9 | 0.990 |
| Fasting plasma glucose (mg/dL) | 85.2 ± 8.1 | 86.7 ± 9.6 | 0.177 |
| Glycated hemoglobin (%) | 5.50 ± 0.36 | 5.50 ± 0.35 | 0.787 |
| HOMA-IR | 1.84 ± 1.16 | 1.86 ± 1.07 | 0.706 |
| Serum cholesterol (mg/dL) | 188.6 ± 36.6 | 192.8 ± 50.3 | 0.656 |
| Serum triglyceride (mg/dL) | 123.4 ± 60.5 | 117.8 ± 53.4 | 0.459 |
| High-density Lipoprotein (HDL) (mg/dL) | 45.5 ± 10.8 | 45.8 ± 9.5 | 0.648 |
| Low-density Lipoprotein (LDL) (mg/dL) | 118.5 ± 31.4 | 123.3 ± 44.4 | 0.486 |
| Serum creatinine (mg/dL) | 0.87 ± 0.18 | 0.97 ± 1.3 | 0.103 |
| Microalbuminuria (mg/dL) | 20.6 ± 44.1 | 12.8 ± 18.9 | 0.543 |
| hsCRP (mg/L) (geo mean) | 1.4 | 3.3 | < 0.001 |
| Carotid intimal medial thickness (IMT) (mm) | 0.71 ± 0.12 | 0.85 ± 0.33 | < 0.001 |
*
CAD = coronary artery disease; HOMAR-IR = homeostasis model of assessment-insulin resistance; hsCRP = high-sensitivity C-reactive protein.